Abstract:Introduction: Vascular stiffening is an independent predictor of cardiovascular diseases, the leading cause of death worldwide. High dietary salt intake has been shown to increase vascular stiffness in humans, especially in salt-sensitive populations. To date, the underlying mechanisms of high salt-induced vascular stiffening remain poorly understood. Our recent study used the deoxycortisone acetate (DOCA)-salt mouse model, which exhibits increased mineralocorticoid levels, and thus replicates a situation of high salt consumption in salt-sensitive humans who do not manifest appropriate suppression of aldosterone production. Our data has revealed a vital role of the endothelial sodium channel (EnNaC) in salt-sensitivity-related endothelial cell (EC) and arterial stiffening. Nevertheless, the exact mechanisms by which DOCA-salt activate EnNaC and cause EC and arterial stiffening are yet to be determined. Further, related studies in renal epithelial cells have shown that SGK1 is a key regulator of sodium channel activity. Thus, in the current study, we hypothesized that EC-SGK1 mediates DOCA-salt-induced EC and arterial stiffening. Methods: To probe signaling pathways, we produced a mouse model with specific deletion of EC-SGK1 by cross-breeding cadherin 5-Cre mice with sgk1 flox/flox mice. The knockout model was validated by genotyping PCR and quantitative PCR. Further, littermate control and EC-SGK1 knockout mice underwent either a sham surgery or were implanted, subcutaneously, with slow-release DOCA pellets (100mg) and given salt (1% NaCl, 0.2% KCl) in their drinking water for 42 days. Blood pressures and pulse wave velocity (PWV) were measured immediately prior to initiating treatments and at the end of the study using tail-cuff and ultrasound, respectively. Thoracic aortae were freshly isolated for measurement of aortic EC stiffness by atomic force microscopy. Results: SGK1 mRNA levels were significantly reduced in ECs but not smooth muscle cells isolated from EC-SGK1 knockout mice as compared to those from littermate control mice. DOCA-salt treated control mice had significantly increased blood pressure which was prevented in EC-SGK1 knockout mice. DOCA-salt-induced increases in PWV and EC stiffness were significantly attenuated by EC-SGK1 deletion. Conclusion: EC-SGK1 knock out mice were successfully produced and used to suggest that EC-SGK1 plays a role in salt-sensitivity related EC and arterial stiffening. Whether this is directly mediated through EC-SGK1 regulation of EnNaC requires further examination. We further conclude that our study may provide potential insights into approaches for developing therapeutic interventions for salt-sensitive hypertension-related cardiovascular dysfunction. This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Abstract 049: Abrogation Of Transglutaminase 2 In Vascular Smooth Muscle Cells Attenuates Doca/salt Induced Hypertension In Male Mice

Abstract 394: Chronic Knockdown of the NTS AT1R Increases Circulating Inflammatory-Endothelial Progenitor Cells Ratio and Exacerbates Hypertension in the SHR

Abstract 17594: Brain Microglial Cytokines are Critical for Renin-Angiotensin-Aldoterone-System(RAAS)-Induced Neurogenic Hypertension

Abstract 8: Deletion Of The Alpha Subunit Of EnNaC And MTORC2 Inhibition Attenuate DOCA-salt-induced Endothelial Cell And Vascular Stiffness.

Pharmacological modulation of transglutaminase 2 in the unilateral ureteral obstruction mouse model

Endothelium-Specific Gtp Cyclohydrolase I Overexpression Attenuates Blood Pressure Progression In Salt-Sensitive Low-Renin Hypertension

OS 36-08 A2A RECEPTOR-MEDIATED ACTIVATION OF REGULATORY T CELLS ATTENUATES HYPERTENSION-INDUCED CARDIOVASCULAR INJURY

Endothelial cell serum and glucocorticoid regulated kinase 1 (SGK1) mediates DOCA-salt-induced endothelial cell and arterial stiffening

A2a Receptor-Mediated Activation Of Regulatory T Cells Attenuates Hypertension-Induced Cardiovascular Injury

The Role of Vascular Smooth Muscle RhoBTB1 in Hypertension

[OP.8C.05] A2A RECEPTOR-MEDIATED ACTIVATION OF REGULATORY T CELLS ATTENUATES HYPERTENSION-INDUCED CARDIORENAL CONSEQUENCE

Abstract 21022: Increasing Cav1.2 in Smooth Muscle Cells Induces Both Systemic and Pulmonary Hypertension Via Inhibiting Endothelium-Dependent Relaxation

Abstract 374: Smooth Muscle Cell-specific Deletion Of At1a Receptor Attenuates Vascular Fibrosis In Angiotensin Ii-infused Mice

Prevention of Angiotensin II-induced Hypertension and Cardiac Remodeling by Recombinant Human Angiotensin-Converting Enzyme 2 in Mice

Abstract 034: ROCK2 Specific Inhibition Decreases Th17/Treg Balance And Reduces DOCA-salt Hypertension-associated End-Organ Damage

Mpges-1 Protects Against DOCA-Salt Hypertension Via Inhibition of Oxidative Stress or Stimulation of NO/cGMP

Vascular smooth muscle cells specific deletion of angiopoietin-like protein 8 prevents angiotensin II-promoted hypertension and cardiovascular hypertrophy

S-12-4: CITE-SEQ IDENTIFIES TREM2-DEPENDENT GENE PROGRAM DRIVING CARDIAC REMODELING IN A HYPERTENSIVE MODEL OF HEART FAILURE WITH PRESERVED EJECTION FRACTION

PS-B09-13: PHARMACOLOGICAL INHIBITION OF INTERLEUKIN-18 REDUCES DEOXYCORTICOSTERONE/SALT-INDUCED HYPERTENSION AND RENAL INFLAMMATION

Abstract 12731: Acute Calcium/Calmodulin-Dependent Protein Kinase II Inhibition Augments Cardiomyocyte Contractility and Improves β-Adrenergic Regulation in Experimental Hypertension of Transgenic Rats Expressing Human Angiotensinogen Gene

DP1 (Prostaglandin D2 Receptor 1) Activation Protects Against Vascular Remodeling and Vascular Smooth Muscle Cell Transition to Myofibroblasts in Angiotensin II–Induced Hypertension in Mice